Allogene Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2018 | $-7.31 | $-9.13 |
| FY2019 | $-1.83 | $-5.69 |
| FY2020 | $-2.63 | $-4.86 |
| FY2021 | $-1.34 | $-4.03 |
| FY2022 | $-2.38 | $-3.73 |
| FY2023 | $-2.09 | $-3.47 |
| FY2024 | $-1.32 | $-3.16 |
| FY2025 | $-0.87 | $-2.88 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2018 | $-7.31 | $-9.13 |
| FY2019 | $-1.83 | $-5.69 |
| FY2020 | $-2.63 | $-4.86 |
| FY2021 | $-1.34 | $-4.03 |
| FY2022 | $-2.38 | $-3.73 |
| FY2023 | $-2.09 | $-3.47 |
| FY2024 | $-1.32 | $-3.16 |
| FY2025 | $-0.87 | $-2.88 |